Newsbytes
  • India
  • Business
  • World
  • Politics
  • Sports
  • Technology
  • Entertainment
  • Auto
  • Lifestyle
  • Inspirational
  • Career
  • Bengaluru
  • Delhi
  • Mumbai
  • Videos
  • Visual Stories
  • Reviews
  • Phone Reviews
  • Fitness Bands Reviews
  • Speakers Reviews
  • Find Cricket Statistics
Hindi
More
In the news
SpaceX
Elon Musk
Space News
OnePlus
Telegram
Realme
Latest Mobile Phones
Newsbytes
Hindi
Newsbytes
User Placeholder

Hi,

Logout


India
Business
World
Politics
Sports
Technology
Entertainment
Auto
Lifestyle
Inspirational
Career
Bengaluru
Delhi
Mumbai
Videos
Visual Stories
Reviews
Phone Reviews
Fitness Bands Reviews
Speakers Reviews
Find Cricket Statistics

More Links
  • Videos

Download Android App

Follow us on
  • Facebook
  • Twitter
  • Linkedin
  • Youtube
 
Home / News / Technology News / Coronavirus: What is herd immunity? And how does it work?
Technology

Coronavirus: What is herd immunity? And how does it work?

Coronavirus: What is herd immunity? And how does it work?
Written by Siddhant Pandey
Jul 08, 2020, 06:54 pm 3 min read
Coronavirus: What is herd immunity? And how does it work?

Since the coronavirus outbreak, several words have entered the common person's lexicon: social distancing, pandemic, self-isolation, asymptomatic, etc. The pandemic has also introduced people to the concept of "herd immunity," a term commonly used in conversations about vaccination. What does it mean? And how is it relevant in the times of COVID-19? Here's all you need to know.

Definition
What is herd immunity?

Herd immunity is when a significant portion of the population has developed immunity against a pathogen. This helps limit the spread of the pathogen through the population by breaking the chain of transmission. For e.g., if 80% of the population is immune, four out of five people who encounter an infected person will not get sick and will hence not transmit the disease further.

Significance
Why is it so important?

Even though you may feel confident about your immune system's capability to fight off an infection, that's not the point. Herd immunity offers some protection for the people who are more vulnerable to infection (elder persons, children, pregnant persons, etc.). There are also people who cannot be vaccinated, or people who have weaker/compromised immune systems—people receiving cancer treatment fall in both categories.

Process
How can herd immunity be achieved?

If a significant portion of the population gets vaccinated against a pathogen, herd immunity is said to have been achieved. For different kinds of pathogens, the "herd immunity threshold"—the percentage of the population required to have immunity to achieve herd immunity—varies. Early estimates say that at least 70% of the population needs to be immune against COVID-19 to achieve herd immunity.

Coronavirus
How is it relevant for COVID-19?

Although herd immunity is mostly talked about in terms of vaccination, there is no vaccine against COVID-19 yet. However, herd immunity can also be achieved naturally. In this process, several people get infected and develop immunity against a pathogen. In the early stages of the coronavirus pandemic, the UK had planned to allow people to get a "mild illness" until herd immunity kicks in.

Information
What's the harm in developing natural immunity?

Since there is no vaccine, developing natural immunity seems like the obvious choice to achieve some form of herd immunity against COVID-19. However, this puts at risk the millions of people who are immunocompromised, have co-morbidities, or are otherwise more vulnerable to infection.

Healthcare system
In process of building natural immunity, health systems may collapse

Further, if too many people get infected, the burden on our healthcare system could be immense, which could lead to higher death rates. The whole point of "flattening the curve" was to avoid that; by following social distancing, so few people get infected, and fewer of them need to be hospitalized. An overwhelmed health system affects not just COVID-19 patients, but all patients.

Research
What does the research say?

A recent large-scale Spanish study had found that only 5% of the population had antibodies against COVID-19. Notably, Spain was one of the worst-hit countries in the outbreak. The study also found the immunity against COVID-19 may not last long. More importantly, researchers remain uncertain if getting infected by the coronavirus or having antibodies against it would even protect you from re-infection.

Information
Immunity against coronavirus will probably not last for life

According to the Johns Hopkins University Bloomberg School of Public Health, if the coronavirus responsible for COVID-19, called SARS-CoV-2, behaves similar to other coronaviruses, immunity against the disease may only last for months or perhaps years, but probably not a lifetime.

Share this timeline
Facebook
Whatsapp
Twitter
Linkedin
Siddhant Pandey
Siddhant Pandey
Twitter
Siddhant Pandey covers national and health news at NewsBytes. He has over five years of experience working as a multimedia journalist covering hard news in New Delhi. He was previously employed with The Indian Express and News World India and has juggled roles as a correspondent, copy editor, and video producer. He holds a Bachelor’s degree in Biotechnology from the Jaypee Institute of Information Technology, Noida.
Latest
Vaccine
Coronavirus
SARS-CoV-2
COVID-19
Related
Latest
Agnipath scheme: Air Force opens registrations for Agniveers from today
Agnipath scheme: Air Force opens registrations for Agniveers from today Career
Instagram will use AI to confirm your age: Here's how
Instagram will use AI to confirm your age: Here's how Technology
Kichcha Sudeep's 'Vikrant Rona' trailer: Looking at its highlights
Kichcha Sudeep's 'Vikrant Rona' trailer: Looking at its highlights Entertainment
Crescent moon joins 'planetary parade': How to watch rare conjunction
Crescent moon joins 'planetary parade': How to watch rare conjunction Technology
Everything we know about Rajkummar Rao's 'HIT: The First Case'
Everything we know about Rajkummar Rao's 'HIT: The First Case' Entertainment
Vaccine
COVID-19: India logs 12,249 fresh cases, 13 more fatalities
COVID-19: India logs 12,249 fresh cases, 13 more fatalities India
COVID-19: India logs 9,923 fresh cases, 17 more fatalities
COVID-19: India logs 9,923 fresh cases, 17 more fatalities India
COVID-19: India logs 12,899 fresh cases, 15 more deaths
COVID-19: India logs 12,899 fresh cases, 15 more deaths India
COVID-19: India reports 13,216 new cases, 23 more deaths
COVID-19: India reports 13,216 new cases, 23 more deaths India
COVID-19: India logs 12,847 new cases, 14 more deaths
COVID-19: India logs 12,847 new cases, 14 more deaths India
More News
Coronavirus
How long does immunity last after COVID-19?
How long does immunity last after COVID-19? Technology
#NewsBytesExplainer: Why experts believe 4th COVID-19 wave is not coming
#NewsBytesExplainer: Why experts believe 4th COVID-19 wave is not coming India
COVID-19: India logs 7,584 fresh cases, 24 more fatalities
COVID-19: India logs 7,584 fresh cases, 24 more fatalities India
COVID-19: India logs 3,303 new cases; 39 more deaths
COVID-19: India logs 3,303 new cases; 39 more deaths India
COVID-19 XE variant reported by Gujarat; detected in 67-year-old man
COVID-19 XE variant reported by Gujarat; detected in 67-year-old man India
More News
SARS-CoV-2
COVID-19 survivors at risk of developing serious blood clots: Study
COVID-19 survivors at risk of developing serious blood clots: Study Technology
Coronavirus may remain active for longer than recommended quarantine: Study
Coronavirus may remain active for longer than recommended quarantine: Study World
China: PCR test purchases increased before COVID-19 was first confirmed
China: PCR test purchases increased before COVID-19 was first confirmed World
Mu, C.1.2 variants of SARS-CoV2 not found in India: INSACOG
Mu, C.1.2 variants of SARS-CoV2 not found in India: INSACOG India
COVID-19 'not developed' as a biological weapon: US Intelligence Community
COVID-19 'not developed' as a biological weapon: US Intelligence Community World
More News
COVID-19
COVID-19: India logs 17,336 new cases, highest in 4 months
COVID-19: India logs 17,336 new cases, highest in 4 months India
Average salary of Indian CEO is over Rs. 11cr: Deloitte
Average salary of Indian CEO is over Rs. 11cr: Deloitte Business
COVID-19: India logs 13,313 fresh cases, 38 more fatalities
COVID-19: India logs 13,313 fresh cases, 38 more fatalities India
Maharashtra: Amid Sena revolt, CM Uddhav Thackeray vacates official residence
Maharashtra: Amid Sena revolt, CM Uddhav Thackeray vacates official residence Politics
International Yoga Day 2022: PM Modi leads celebrations at Mysuru
International Yoga Day 2022: PM Modi leads celebrations at Mysuru India
More News
Related
COVID-19: Everything to know about Delta, Delta-Plus, Kappa, Lambda variants
COVID-19: Everything to know about Delta, Delta-Plus, Kappa, Lambda variants India
Next News Article
Next News Article

Love Technology news?

Subscribe to stay updated.

Science Thumbnail
India News Business News World News Politics News Sports News Technology News Entertainment News Auto News Lifestyle News Inspirational News
Career News Bengaluru News Delhi News Mumbai News Mukesh Ambani Indian Premier League (IPL) Karnataka Samsung Xiaomi West Bengal
Bihar Virat Kohli Rohit Sharma Haryana Narendra Modi Arvind Kejriwal Tamil Nadu Gujarat Yogi Adityanath YouTube
Instagram Hollywood News Uttar Pradesh Kerala Netflix Bollywood News Mamata Banerjee Maruti Suzuki Rahul Gandhi Elon Musk
Shah Rukh Khan Chelsea FC OPPO Akhilesh Yadav Indian Cricket Team Apple Manchester United Salman Khan Cryptocurrency OnePlus
Amitabh Bachchan ICC Women's World Cup Vivo India vs Sri Lanka
About Us Privacy Policy Terms & Conditions Contact Us Ethical Conduct Grievance Redressal News News Archive Topics Archive IPL 2022 Schedule IPL 2022 Points Table Find Cricket Statistics
Follow us on
Facebook Twitter Linkedin Youtube
All rights reserved © NewsBytes 2022